x

Cancer

Stephen Housley and Tim Cope
BME Researchers Aim to Stop Chemo Neuro Damage Before It Starts

New grant from NIH supporting Cope lab’s work focused on long-term effects from platinum-based cancer drugs

Co-lead author Ali Zamat and Gabe Kwong look over their work.
Heat-Controllable CAR T Cells Destroy Tumors, Prevent Relapse in New Study

A cell chamber is mounted on a microscope. Three micropipettes, inserted into the chamber from both sides, are used to aspirate individual cells, to bring them into contact so that researchers can study their interactions. This is the kind of methodology that Cheng Zhu and his colleagues used to study PD-1.
Zhu Lab Explains the Inhibitory Role of World’s Most Famous Molecule

Cheng Zhu leads study of immune system protein that helps control T cell activity

Melissa Kemp and Josh Lewis (Photo: Joshua Stewart)
Targeting Radiation Resistance: Why Some Tumors Are So Stubborn

Kemp lab uses genome-scale modeling to understand tumor metabolism and predict tumors’ responses to radiation therapy

Melissa Kemp and Josh Lewis have used genome-scale modeling to predict tumors’ responses to radiation therapy.
Targeting Radiation Resistance: Why Some Tumors Are So Stubborn

Kemp lab uses genome-scale modeling to understand tumor metabolism and predict tumors’ responses to radiation therapy
Yutong Guo and Costas Arvanitis
Breaching the Blood-Brain Barrier to Deliver Precious Payloads

Georgia Tech and Emory researchers use ultrasound to develop delivery system for potent RNA drugs
Technology from the Zhu lab: A cell chamber is mounted on a microscope. Three micropipettes, inserted into the chamber from both sides, are used to aspirate individual cells, to bring them into contact so that researchers can study their interactions. This is the kind of methodology that Cheng Zhu and his colleagues used to study PD-1, which might be the most famous molecule in the world. 
Zhu Lab Explains the Inhibitory Role of World’s Most Famous Molecule

New research teases apart the mechanisms behind the checkpoint protein PD-1